Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Program Cuts Loom If ‘Cures’ Bill Isn’t Fully Funded, Ostroff Warns

This article was originally published in The Pink Sheet Daily

Executive Summary

FDA’s acting commissioner says agency may have to ‘stop doing something else’ in order to cover the new responsibilities envisioned in the Cures legislation.

You may also be interested in...



US FDA's Ostroff, Twice An Acting Commissioner, Retiring Next Year

A former Walmart executive will replace the deputy commissioner for foods and veterinary medicine, who spent nearly 15 months total as acting commissioner.

Califf Sets Exit At FDA, Ostroff Could Return To Acting Commissioner Post

Former acting commissioner in line for the temporary position again under FDA policy, unless incoming Trump administration designates someone else.

US FDA Might Be Temporarily Headed By Ostroff As Califf Sets His Departure

Former acting commissioner in line for the temporary position again under FDA policy, unless incoming Trump administration designates someone else.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS078644

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel